Investing.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期,推动股价上涨2.8%,投资者对公司强劲表现和乐观前景反应积极。 这家制药公司第二季度调整后每股收益为0.40美元,显著超过分析师共识的0.04美元。营收达到25.3亿美元,高于预期的24.8亿美元,较去年同期的24亿美元...
Source LinkInvesting.com -- 鲍什健康公司(Bausch Health Companies Inc)(NYSE:BHC)(TSX:BHC)公布的第二季度财报大幅超出分析师预期,推动股价上涨2.8%,投资者对公司强劲表现和乐观前景反应积极。 这家制药公司第二季度调整后每股收益为0.40美元,显著超过分析师共识的0.04美元。营收达到25.3亿美元,高于预期的24.8亿美元,较去年同期的24亿美元...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.